US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 138.000
  • +0.330+0.24%
Close Jan 2 16:00 ET
  • 138.000
  • 0.0000.00%
Post 16:00 ET
8.25BMarket Cap-18.02P/E (TTM)

Ascendis Pharma A/S Key Stats

Ascendis Pharma A/S Q3 2024 Earnings Date

Currency:USDNov 14, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
78.21M
64.40M
-13.81M
Miss Est.
+53.99%
+26.80%
-17.66%
EPS
-1.62
-1.92
-0.29
Miss Est.
+46.74%
+37.10%
-18.08%
Strong Buy

Dec 31, 2024

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 91.920M--
--2024/Q4-- / 97.732M--
Nov 14, 20242024/Q357.833M / 70.236M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 91.920M--
--2024/Q4-- / 97.732M--
Nov 14, 20242024/Q357.833M / 70.236M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    92.31%
  • Hold

    7.69%
  • Sell

    0.00%

Price Target

No Data